caa a22 4500 477126405 CHVBK 20180405111651.0 cr unu---uuuuu 170330e19970701xx s 000 0 eng 10.1023/A:1012135430056 doi (NATIONALLICENCE)springer-10.1023/A:1012135430056 Scale-up of Adhesive Transdermal Drug Delivery Systems [Elektronische Daten] [Glenn Van Buskirk, Mario González, Vinod Shah, Scott Barnhardt, Colin Barrett, Stephen Berge, Gary Cleary, Keith Chan, Gordon Flynn, Thomas Foster, Robert Gale, Raymond Garrison, Scott Gochnour, Amanda Gotto, Sharad Govil, Vivian Gray, James Hammar, Samuel Harder, Charles Hoiberg, Ajaz Hussain, Carol Karp, Hector Llanos, Juan Mantelle, Patrick Noonan, David Swanson, Horst Zerbe] Plenum Publishing Corporation, 1997 SUPAC nationallicence adhesive transdermal systems nationallicence scale-up nationallicence post approval changes nationallicence Van Buskirk Glenn Novartis Pharmaceuticals Corp., 59 Route 10, 07936, East Hanover, New Jersey aut González Mario P'Kinetics, Inc., Miami, Florida aut Shah Vinod Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut Barnhardt Scott Hercon Laboratory Corp., Emigsville, Pennsylvania aut Barrett Colin Elan Corporation, Athlone, Ireland aut Berge Stephen 3M Pharmaceuticals, St. Paul, Minnesota aut Cleary Gary Cygnus Inc., Redwood City, California aut Chan Keith University of Maryland, Baltimore, Maryland aut Flynn Gordon University of Michigan, Ann Arbor, Michigan aut Foster Thomas University of Kentucky, Lexington, Kentucky aut Gale Robert Alza Corp., Palo Alto, California aut Garrison Raymond Novartis Pharmaceuticals Corp., Suffern, New York aut Gochnour Scott Theratec, Inc, Salt Lake City, Utah aut Gotto Amanda Novartis Pharmaceuticals Corp., Suffern, New York aut Govil Sharad Bertek, Inc., St. Albans, Vermont aut Gray Vivian USP, Rockville, Maryland aut Hammar James 3M Pharmaceuticals, St. Paul, Minnesota aut Harder Samuel 3M Pharmaceuticals, St. Paul, Minnesota aut Hoiberg Charles Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut Hussain Ajaz Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut Karp Carol Cygnus Inc., Redwood City, California aut Llanos Hector Schering Laboratories, Miami Lakes, Florida aut Mantelle Juan Noven Pharmaceuticals, Miami, Florida aut Noonan Patrick Pharmaco International, Richmond, Virginia aut Swanson David Alza Corp., Palo Alto, California aut Zerbe Horst Lohmann Therapeutic Systems, West Caldwell, New Jersey aut Pharmaceutical Research Kluwer Academic Publishers-Plenum Publishers 14/7(1997-07-01), 848-852 0724-8741 14:7<848 1997 14 11095 https://doi.org/10.1023/A:1012135430056 text/html Onlinezugriff via DOI 1 article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1012135430056 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Van Buskirk Glenn Novartis Pharmaceuticals Corp., 59 Route 10, 07936, East Hanover, New Jersey aut NATIONALLICENCE 700 1- González Mario P'Kinetics, Inc., Miami, Florida aut NATIONALLICENCE 700 1- Shah Vinod Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut NATIONALLICENCE 700 1- Barnhardt Scott Hercon Laboratory Corp., Emigsville, Pennsylvania aut NATIONALLICENCE 700 1- Barrett Colin Elan Corporation, Athlone, Ireland aut NATIONALLICENCE 700 1- Berge Stephen 3M Pharmaceuticals, St. Paul, Minnesota aut NATIONALLICENCE 700 1- Cleary Gary Cygnus Inc., Redwood City, California aut NATIONALLICENCE 700 1- Chan Keith University of Maryland, Baltimore, Maryland aut NATIONALLICENCE 700 1- Flynn Gordon University of Michigan, Ann Arbor, Michigan aut NATIONALLICENCE 700 1- Foster Thomas University of Kentucky, Lexington, Kentucky aut NATIONALLICENCE 700 1- Gale Robert Alza Corp., Palo Alto, California aut NATIONALLICENCE 700 1- Garrison Raymond Novartis Pharmaceuticals Corp., Suffern, New York aut NATIONALLICENCE 700 1- Gochnour Scott Theratec, Inc, Salt Lake City, Utah aut NATIONALLICENCE 700 1- Gotto Amanda Novartis Pharmaceuticals Corp., Suffern, New York aut NATIONALLICENCE 700 1- Govil Sharad Bertek, Inc., St. Albans, Vermont aut NATIONALLICENCE 700 1- Gray Vivian USP, Rockville, Maryland aut NATIONALLICENCE 700 1- Hammar James 3M Pharmaceuticals, St. Paul, Minnesota aut NATIONALLICENCE 700 1- Harder Samuel 3M Pharmaceuticals, St. Paul, Minnesota aut NATIONALLICENCE 700 1- Hoiberg Charles Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut NATIONALLICENCE 700 1- Hussain Ajaz Center of Drug Evaluation & Research, FDA, Rockville, Maryland aut NATIONALLICENCE 700 1- Karp Carol Cygnus Inc., Redwood City, California aut NATIONALLICENCE 700 1- Llanos Hector Schering Laboratories, Miami Lakes, Florida aut NATIONALLICENCE 700 1- Mantelle Juan Noven Pharmaceuticals, Miami, Florida aut NATIONALLICENCE 700 1- Noonan Patrick Pharmaco International, Richmond, Virginia aut NATIONALLICENCE 700 1- Swanson David Alza Corp., Palo Alto, California aut NATIONALLICENCE 700 1- Zerbe Horst Lohmann Therapeutic Systems, West Caldwell, New Jersey aut NATIONALLICENCE 773 0- Pharmaceutical Research Kluwer Academic Publishers-Plenum Publishers 14/7(1997-07-01), 848-852 0724-8741 14:7<848 1997 14 11095 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer